bioRxivMicrobiologyPreprint
A functional genetic landscape of antibiotic sensitivity across the pneumococcal pangenome reveals conserved and lineage-specific vulnerabilities
Bevika SewgoolamiD, Axel B. JansseniD, Louise MartiniD, Rengifo-Gonzalez Monica, Vincent de BakkeriD, Babet Rozendal, Amelieke J. H. CremersiD, Jan‐Willem VeeningiD
Abstract
The large pangenome of Streptococcus pneumoniae enables this opportunistic pathogen to adapt and evade antibiotic treatment. Effective treatment of pneumococcal infections requires a better understanding of the genes that modulate susceptibility to antibiotics across the pangenome. Using CRISPRi-seq, we identified genes that contribute to antibiotic sensitivity against a panel of clinically relevant antibiotics across nine pneumococcal strains with diverse resistance profiles, serotypes, and lineages. The here-generated chemical-genetics atlas revealed distinct genome-wide signatures of antibiotic stress that were specific to the antibiotic mode of action and showed both strain-specific and conserved signatures. This allowed us to identify conserved genes involved in antibiotic vulnerability and assign functions to previously uncharacterized genes. For instance, deletion of mutS2, which may act as a ribosome collision sensor and spv_1295, a conserved gene of unknown function, resulted in increased sensitivity to the macrolide azithromycin across strains, including a macrolide resistant strain, and could be potential targets for global sensitizing therapies. This work establishes a pangenome-wide framework for understanding antibiotic stress responses in S. pneumoniae, providing a foundation for the rational development of therapies that exploit conserved and strain-specific vulnerabilities.
- organism: human
- assay: CRISPR screen
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance.
D. Leshchiner, F. Rosconi, … T. van Opijnen·bioRxiv·Jan 26, 2022
- Strain-resolved CRISPRi-Seq reveals conserved antibiotic vulnerabilities in Staphylococcus aureus
Maria-Vittoria Mazzuoli, Jessica Burnier, … Jan‐Willem Veening·bioRxiv·Oct 13, 2025
- In vivo genome-wide CRISPRi-Seq in Streptococcus pneumoniae reveals host-adaptive pathways essential for meningitis and identifies new therapeutic targets
Kin Ki Jim, Andrew Quinn, … Jan‐Willem Veening·bioRxiv·Oct 31, 2025
- Sorafenib, a clinically approved kinase inhibitor attenuates Streptococcus pneumoniae pathogenesis in vivo by targeting serine/threonine kinase StkP
Joel Abraham, Aswathy C. Sagilkumar, … Karthik Subramanian·mBioPeer-reviewed·Jun 16, 2026
- Genome analysis of clinical pneumococcal isolates to decipher sequence types, antibiotic resistance mechanisms and virulence gene profiles
S. C. M. Peela, S. Rose, S. Sistla·bioRxiv·Jul 21, 2020
- Characterization of a novel gene, srpA, conferring resistance to streptogramin A, pleuromutilins, and lincosamides in Streptococcus suis